EDAP TMSEDAP
Market Cap: $113M
About: Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.
Employees: 307
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
8% less funds holding
Funds holding: 37 [Q1] → 34 (-3) [Q2]
9.82% less ownership
Funds ownership: 52.81% [Q1] → 42.99% (-9.82%) [Q2]
33% less funds holding in top 10
Funds holding in top 10: 3 [Q1] → 2 (-1) [Q2]
36% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 11
39% less capital invested
Capital invested by funds: $143M [Q1] → $86.8M (-$56.6M) [Q2]
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
71% less call options, than puts
Call options by funds: $378K | Put options by funds: $1.29M
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
2 analyst ratings
HC Wainwright & Co. Swayampakula Ramakanth 30% 1-year accuracy 39 / 128 met price target | 523%upside $19 | Buy Reiterated | 29 Aug 2024 |
HC Wainwright & Co. Swayampakula Ramakanth 30% 1-year accuracy 39 / 128 met price target | 523%upside $19 | Buy Reiterated | 22 Jul 2024 |
Financial journalist opinion
Based on 4 articles about EDAP published over the past 30 days